JPH07215832A - Skin external preparation - Google Patents
Skin external preparationInfo
- Publication number
- JPH07215832A JPH07215832A JP2603794A JP2603794A JPH07215832A JP H07215832 A JPH07215832 A JP H07215832A JP 2603794 A JP2603794 A JP 2603794A JP 2603794 A JP2603794 A JP 2603794A JP H07215832 A JPH07215832 A JP H07215832A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- acid
- external preparation
- erythritol
- nmf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 32
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000004386 Erythritol Substances 0.000 claims abstract description 21
- 229940009714 erythritol Drugs 0.000 claims abstract description 21
- 235000019414 erythritol Nutrition 0.000 claims abstract description 21
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 21
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000004310 lactic acid Substances 0.000 claims abstract description 6
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 230000003020 moisturizing effect Effects 0.000 claims description 14
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 7
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 6
- 229910021293 PO 4 Inorganic materials 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 24
- 239000004615 ingredient Substances 0.000 abstract description 3
- 150000001860 citric acid derivatives Chemical class 0.000 abstract 1
- 239000003906 humectant Substances 0.000 abstract 1
- 150000003893 lactate salts Chemical class 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 63
- -1 alkali metal salts Chemical class 0.000 description 23
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000002253 acid Substances 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- 206010015150 Erythema Diseases 0.000 description 8
- 239000004166 Lanolin Substances 0.000 description 8
- 231100000321 erythema Toxicity 0.000 description 8
- 235000019388 lanolin Nutrition 0.000 description 8
- 229940039717 lanolin Drugs 0.000 description 8
- 206010039509 Scab Diseases 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 239000002304 perfume Substances 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 238000007788 roughening Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 235000021355 Stearic acid Nutrition 0.000 description 5
- 229940001447 lactate Drugs 0.000 description 5
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 5
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 5
- 239000001540 sodium lactate Substances 0.000 description 5
- 235000011088 sodium lactate Nutrition 0.000 description 5
- 229940005581 sodium lactate Drugs 0.000 description 5
- 229940032094 squalane Drugs 0.000 description 5
- 239000008117 stearic acid Substances 0.000 description 5
- 210000000434 stratum corneum Anatomy 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000003405 preventing effect Effects 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 239000004204 candelilla wax Substances 0.000 description 3
- 235000013868 candelilla wax Nutrition 0.000 description 3
- 229940073532 candelilla wax Drugs 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 239000004203 carnauba wax Substances 0.000 description 3
- 235000013869 carnauba wax Nutrition 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 239000000845 maltitol Substances 0.000 description 3
- 235000010449 maltitol Nutrition 0.000 description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 3
- 229940035436 maltitol Drugs 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- KFEASMMSZNLDSB-UHFFFAOYSA-N 12-(12-hydroxydodecoxy)dodecan-1-ol Chemical compound OCCCCCCCCCCCCOCCCCCCCCCCCCO KFEASMMSZNLDSB-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 241000218657 Picea Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 2
- 239000001639 calcium acetate Substances 0.000 description 2
- 235000011092 calcium acetate Nutrition 0.000 description 2
- 229960005147 calcium acetate Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- PHZLMBHDXVLRIX-UHFFFAOYSA-M potassium lactate Chemical compound [K+].CC(O)C([O-])=O PHZLMBHDXVLRIX-UHFFFAOYSA-M 0.000 description 2
- 239000001521 potassium lactate Substances 0.000 description 2
- 235000011085 potassium lactate Nutrition 0.000 description 2
- 229960001304 potassium lactate Drugs 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-Threitol Natural products OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 241000720950 Gluta Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 1
- 241000269799 Perca fluviatilis Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000219053 Rumex Species 0.000 description 1
- KYWSCMDFVARMPN-LCSVLAELSA-N Saikosaponin D Chemical compound O([C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@]([C@H]3[C@]([C@@H]4[C@@]([C@@]5(C[C@@H](O)[C@]67CO[C@]5([C@@H]6CC(C)(C)CC7)C=C4)C)(C)CC3)(C)CC2)(C)CO)O[C@@H]([C@@H]1O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KYWSCMDFVARMPN-LCSVLAELSA-N 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- SDIXRDNYIMOKSG-UHFFFAOYSA-L disodium methyl arsenate Chemical compound [Na+].[Na+].C[As]([O-])([O-])=O SDIXRDNYIMOKSG-UHFFFAOYSA-L 0.000 description 1
- CXPOFJRHCFPDRI-UHFFFAOYSA-N dodecylbenzene;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCC1=CC=CC=C1 CXPOFJRHCFPDRI-UHFFFAOYSA-N 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000010181 horse chestnut Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N isopropyl alcohol Natural products CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 239000002362 mulch Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000008975 pantethine Nutrition 0.000 description 1
- 239000011581 pantethine Substances 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 229960000903 pantethine Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229930192014 saikosaponin Natural products 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 235000002374 tyrosine Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は皮膚外用剤、特に、肌荒
れ改善効果の高い皮膚外用剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a skin external preparation, and more particularly to a skin external preparation having a high skin roughening improving effect.
【0002】[0002]
【従来の技術】化粧品等の皮膚外用剤の大きな目的の一
つは美肌状態の維持である。美肌状態を保つためには、
肌荒れを防止、改善し、肌の皮溝、皮丘を整え、表皮細
胞のターンオーバーをスムーズにすることが重要であ
り、従来より、スキンケア基剤として水分、油分を補給
するクリームや乳液が用いられたり、各種保湿剤が配合
されてきた。特に、自然保湿因子(NMF:natural mo
isturizing factor)は皮膚の保湿に重要な役割を果し
ていることが明らかになって以来、化粧料をはじめとす
る皮膚外用剤に配合されている。2. Description of the Related Art One of the major purposes of external preparations for skin such as cosmetics is to maintain a beautiful skin condition. To maintain beautiful skin,
It is important to prevent and improve the roughness of the skin, prepare the skin's furrows and cuticles, and smooth the turnover of epidermal cells. Traditionally, creams and milky lotions that replenish water and oil have been used as the skin care base. And various moisturizers have been added. In particular, natural moisturizing factor (NMF)
Since it was revealed that isturizing factor) plays an important role in moisturizing the skin, it has been incorporated into external skin preparations such as cosmetics.
【0003】[0003]
【発明が解決しようとする課題】しかしながら、自然保
湿因子は低濃度では肌荒れ改善効果が弱く、また、効果
を十分に発揮するために高濃度に配合すると肌に対する
刺激性が発生するという問題点があった。本発明は、前
記従来技術の課題に鑑みなされたものであり、その目的
は、優れた肌荒れ防止、改善効果を有し、且つ、皮膚ト
ラブルの少ない皮膚外用剤を提供することにある。However, the natural moisturizing factor has a problem that the skin roughening improving effect is weak at a low concentration, and that when it is blended at a high concentration to sufficiently exert the effect, irritation to the skin occurs. there were. The present invention has been made in view of the above problems of the prior art, and an object thereof is to provide an external preparation for skin which has excellent effects of preventing and improving rough skin and has less skin trouble.
【0004】[0004]
【課題を解決するための手段】本発明者らは、前記目的
を達成するために鋭意研究を重ねた結果、自然保湿因子
にエリスリトールを併用すると肌荒れ防止、改善効果が
向上するばかりでなく、皮膚刺激の発生が少ないことを
見出し本発明を完成するに至った。すなわち、本発明の
請求項1記載の皮膚外用剤は自然保湿因子(NMF)成
分の1種又は2種以上とエリスリトールとを配合するこ
とを特徴とする。Means for Solving the Problems As a result of intensive studies for achieving the above-mentioned object, the present inventors have found that not only the use of natural moisturizing factor in combination with erythritol improves skin roughening prevention and improvement effects, but also The inventors have found that the occurrence of irritation is small and have completed the present invention. That is, the external skin preparation according to claim 1 of the present invention is characterized by containing one or more natural moisturizing factor (NMF) components and erythritol.
【0005】また、本発明の請求項2記載の皮膚外用剤
は、請求項1記載の皮膚外用剤において自然保湿因子
(NMF)成分として乳酸及び/又は乳酸塩を配合する
ことを特徴とする。請求項3記載の皮膚外用剤は、請求
項1記載の皮膚外用剤において、自然保湿因子(NM
F)成分としてクエン酸及び/又はクエン酸塩を配合す
ることを特徴とする。請求項4記載の皮膚外用剤は、請
求項1記載の皮膚外用剤において、自然保湿因子(NM
F)成分としてNa+、Ca2+、Mg2+、K+、PO4 3-
又はCl-の中から少なくとも1種以上を配合すること
を特徴とする。The external preparation for skin according to claim 2 of the present invention is characterized in that in the external preparation for skin according to claim 1, lactic acid and / or lactate is added as a natural moisturizing factor (NMF) component. The external skin preparation according to claim 3 is the external skin preparation according to claim 1, which is a natural moisturizing factor (NM).
It is characterized in that citric acid and / or citrate is added as the component (F). The external preparation for skin according to claim 4 is the external preparation for skin according to claim 1, which is a natural moisturizing factor (NM).
F) as components Na + , Ca 2+ , Mg 2+ , K + , PO 4 3-
Alternatively, at least one or more of Cl − is blended.
【0006】以下本発明の構成について詳述する。本発
明にかかる自然保湿因子(以下NMFと略する)とは角
質中に存在する親水性の吸湿物質であり、表1に示すよ
うな組成を有することが知られている。The structure of the present invention will be described in detail below. The natural moisturizing factor (hereinafter abbreviated as NMF) according to the present invention is a hydrophilic hygroscopic substance existing in keratin and is known to have a composition as shown in Table 1.
【表1】 ─────────────────────────────────── (NMF成分) (組成) アミノ酸類 40 % ピロリドンカルボン酸(PCA) 12 乳酸塩 12 尿素 7 NH3、尿酸、グルコサミン、クレアチニン 1.5 クエン酸塩 0.5 Na、Ca、Mg、K、PO4、Cl 18.5 糖、有機酸、ペプチド等 8.5 ───────────────────────────────────[Table 1] ─────────────────────────────────── (NMF component) (Composition) Amino acids 40% Pyrrolidonecarboxylic acid (PCA) 12 Lactate 12 Urea 7 NH 3 , Uric acid, Glucosamine, Creatinine 1.5 Citrate 0.5 Na, Ca, Mg, K, PO 4 , Cl 18.5 Sugar, organic acid, peptide Etc. 8.5 ────────────────────────────────────
【0007】本発明において用いられるNMFとして
は、表1に記載のNMF成分が挙げられるが、好ましく
は乳酸及び/又は乳酸塩、クエン酸及び/又はクエン酸
塩、Na+、Ca2+、Mg2+、K+、PO4 3-、Cl-のイ
オンであり、さらに好ましくは乳酸及び/又は乳酸塩、
クエン酸及び/又はクエン酸塩である。乳酸塩、クエン
酸塩としては、特に限定されないが、ナトリウム塩、カ
リウム塩等のアルカリ金属塩や、カルシウム塩、マグネ
シウム塩等のアルカリ土類金属塩、アンモニウム塩など
が挙げられる。また、前記イオンとしては、NaCl、
CaCl2、KCl、Na3PO4、K2HPO4、H3PO
4、HCl等の無機塩の他、酢酸ナトリウム、酢酸カリ
ウム等の有機酸塩の形でも配合することができる。The NMF used in the present invention includes the NMF components shown in Table 1, preferably lactic acid and / or lactate, citric acid and / or citrate, Na + , Ca 2+ , Mg. 2+ , K + , PO 4 3− , Cl − ions, more preferably lactic acid and / or lactate,
Citric acid and / or citrate. The lactate and citrate are not particularly limited, and examples thereof include alkali metal salts such as sodium salt and potassium salt, alkaline earth metal salts such as calcium salt and magnesium salt, and ammonium salt. Further, as the ions, NaCl,
CaCl 2 , KCl, Na 3 PO 4 , K 2 HPO 4 , H 3 PO
4 In addition to inorganic salts such as HCl, organic acid salts such as sodium acetate and potassium acetate can be added.
【0008】本発明においてはこれらNMF成分を1種
又は2種以上配合することができる。また、本発明にお
けるNMFの配合量は皮膚外用剤全量中に0.01〜3
0重量%が好ましく、さらに好ましくは0.01〜20
重量%である。0.01重量%未満では本発明の効果が
十分に発揮されず、30重量%を超えて配合しても配合
量の増加に見合った効果の増大は期待できない。In the present invention, one or more of these NMF components can be blended. The amount of NMF used in the present invention is 0.01 to 3 based on the total amount of the skin external preparation.
0% by weight is preferable, and more preferably 0.01 to 20.
% By weight. If the amount is less than 0.01% by weight, the effect of the present invention is not sufficiently exhibited, and if the amount is more than 30% by weight, the effect corresponding to the increase in the amount of the compound cannot be expected.
【0009】本発明に用いられるエリスリトールはメソ
−エリスリトールとも呼ばれ、天然界では地衣、担子
菌、果実などに含まれる4炭糖の糖アルコールである。
本発明におけるエリスリトールの配合量は皮膚外用剤全
量中に0.1〜30重量%が好ましく、さらに好ましく
は1〜20重量%である。0.1重量%未満では本発明
の効果が十分に発揮されず、30重量%を超えて配合し
ても配合量の増加に見合った効果の増大は期待できな
い。Erythritol used in the present invention is also called meso-erythritol, and is a sugar alcohol of 4 carbon sugars contained in lichens, basidiomycetes, fruits and the like in the natural world.
The amount of erythritol used in the present invention is preferably 0.1 to 30% by weight, and more preferably 1 to 20% by weight, based on the total amount of the external preparation for skin. If it is less than 0.1% by weight, the effect of the present invention is not sufficiently exerted, and if it exceeds 30% by weight, the effect corresponding to the increase of the compounding amount cannot be expected.
【0010】本発明の皮膚外用剤においては、NMFと
エリスリトールとを併用することにより、それぞれ単独
で使用した場合に比して肌荒れ改善効果が相乗的に向上
する。本発明の皮膚外用剤は化粧料、医薬品、医薬部外
品等、外皮に適用されるものを指し、その剤型は水溶液
系、可溶化系、乳化系、粉末系、油液系、ゲル系、軟膏
系、水−油2層系、水−油−粉末3層系等幅広い形態を
取り得る。In the external preparation for skin of the present invention, the combined use of NMF and erythritol synergistically improves the rough skin improving effect as compared with the case where they are used alone. The external preparation for skin of the present invention refers to cosmetics, pharmaceuticals, quasi drugs, etc. applied to the outer skin, and its dosage form is an aqueous solution-based, solubilized-based, emulsion-based, powder-based, oil-based, gel-based system. , An ointment system, a water-oil two-layer system, a water-oil-powder three-layer system, and the like.
【0011】本発明の皮膚外用剤には上記必須成分の他
に通常化粧料や医薬品等の皮膚外用剤に用いられる他の
成分を本発明の効果を損なわない範囲で配合することが
できる。例えば、二酸化チタン、マイカ、タルク等の粉
末成分、アボガド油、トウモロコシ油、オリーブ油、ナ
タネ油、月見草油、ヒマシ油、ヒマワリ油、茶実油、コ
メヌカ油、ホホバ油、カカオ油、ヤシ油、スクワレン、
スクワラン、牛脂、モクロウ、ミツロウ、キャンデリラ
ロウ、カルナバロウ、鯨ロウ、ラノリン、シリコン油、
流動パラフィン、セレシン、ワセリン、ポリオキシエチ
レン(8モル)オレイルアルコールエーテル、モノオレ
イン酸グリセリル等の油分、カプリルアルコール、ラウ
リルアルコール、ミリスチルアルコール、セチルアルコ
ール等の高級アルコール、コレステロール、フィトステ
ロール等のステロール、カプリン酸、ラウリン酸、ミリ
スチン酸、パルミチン酸、ステアリン酸、ベヘニン酸、
ラノリン脂肪酸、リノール酸、リノレン酸等の高級脂肪
酸、パラアミノ安息香酸、ホモメンチル−7N−アセチ
ルアラントラニレート、ブチルメトキシベンゾイルメタ
ン、ジ−パラメトキシケイ皮酸−モノ−2−エチルヘキ
サン酸グリセリル、アミルサリシレート、オクチルシン
ナメート、2,4−ジヒドロキシベンゾフェノン等の紫
外線吸収剤、ポリエチレングリコール、グリセリン、ソ
ルビトール、キシリトール、マルチトール、ムコ多糖、
ヒアルロン酸、コンドロイチン硫酸、キトサン等の保湿
剤、メチルセルロース、エチルセルロース、アラビアガ
ム、ポリビニルアルコール、モンモリロナイト、ラボナ
イト等の増粘剤、エタノール、1,3−ブチレングリコ
ール等の有機溶剤、ブチルヒドロキシトルエン、トコフ
ェロール、フィチン酸等の酸化防止剤、安息香酸、サリ
チル酸、ソルビン酸、パラオキシ安息香酸アルキルエス
テル(エチルパラベン、ブチルパラベン等)、ヘキサク
ロロフェン等の抗菌防腐剤、グリシン、アラニン、バリ
ン、ロイシン、セリン、トレオニン、フェニルアラニ
ン、チロシン、アスパラギン酸、アスパラギン、グルタ
ミン、タウリン、アルギニン、ヒスチジン等のアミノ酸
及びこれらのアルカリ金属塩と塩酸塩、アシルサルコシ
ン酸(例えばラウロイルメチルサルコシンナトリウム
等)、グルタチオン、リンゴ酸、酒石酸等の有機酸、ビ
タミンA及びその誘導体、ビタミンB6塩酸塩、ビタミ
ンB6トリパルミテート、ビタミンB6ジオクタノエー
ト、ビタミンB2及びその誘導体、ビタミンB12、ビタ
ミンB 15及びその誘導体等のビタミンB類、アスコルビ
ン酸、アスコルビン酸硫酸エステル(塩)、アスコルビ
ン酸リン酸エステル(塩)、アスコルビン酸ジパルミテ
ート等のビタミンC類、α−トコフェロール、β−トコ
フェロール、γ−トコフェロール、ビタミンEアセテー
ト、ビタミンEニコチネート等のビタミンE類、ビタミ
ンD類、ビタミンH、パントテン酸、パンテチン等のビ
タミン類、ニコチン酸アミド、ニコチン酸ベンジル、γ
−オリザノール、アラントイン、グリチルリチン酸
(塩)、グリチルレチン酸及びその誘導体、ヒノキチオ
ール、ムシジン、ビサボロール、ユーカリプトール、チ
モール、イノシトール、サポニン類(サイコサポニン、
ニンジンサポニン、ヘチマサポニン、ムクロジサポニン
等)、パントテニルエチルエーテル、エチニルエストラ
ジオール、セファランチン、プラセンタエキス等の各種
薬剤、ギシギシ、クララ、コウホネ、オレンジ、セー
ジ、ノコギリソウ、ゼニアオイ、センキュウ、センブ
リ、タイム、トウキ、トウヒ、パーチ、スギナ、ヘチ
マ、マロニエ、ユキノシタ、アルニカ、ユリ、ヨモギ、
シャクヤク、アロエ、クチナシ、サワラ等の植物の有機
溶媒、アルコール、多価アルコール、水、水性アルコー
ル等で抽出した天然エキス、色素、モノラウリン酸ソル
ビタン、モノパルミチン酸ソルビタン、セスキオレイン
酸ソルビタン、トリオレイン酸ソルビタン、モノラウリ
ン酸ポリオキシエチレンソルビタン、モノステアリン酸
ポリオキシエチレンソルビタン、ポリエチレングリコー
ルモノオレエート、ポリオキシエチレンアルキルエーテ
ル、ポリグリコールジエステル、ラウロイルジエタノー
ルアマイド、脂肪酸イソプロパノールアマイド、マルチ
トールヒドロキシ脂肪族エーテル、アルキル化多糖、ア
ルキルグルコシド、シュガーエステル等の非イオン性界
面活性剤、ステアリルトリメチルアンモニウムクロライ
ド、塩化ベンザルコニウム、ラウリルアミンオキサイド
等のカチオン性界面活性剤、パルミチン酸ナトリウム、
ラウリン酸ナトリウム、ラウリル硫酸ナトリウム、ラウ
リル硫酸カリウム、アルキル硫酸トリエタノールアミン
エーテル、ロート油、リニアドデシルベンゼン硫酸、ポ
リオキシエチレン硬化ヒマシ油マレイン酸、アシルメチ
ルタウリン等のアニオン性界面活性剤、両性界面活性
剤、香料、精製水等を配合することができる。In addition to the above essential components, the external preparation for skin of the present invention
Other skin external preparations such as cosmetics and pharmaceuticals
The components may be blended within a range that does not impair the effects of the present invention.
it can. For example, powders of titanium dioxide, mica, talc, etc.
Powdered ingredients, avocado oil, corn oil, olive oil, na
Seed oil, evening primrose oil, castor oil, sunflower oil, tea seed oil, coconut oil
Menuka oil, jojoba oil, cocoa oil, coconut oil, squalene,
Squalane, beef tallow, owl, beeswax, candelilla
Wax, carnauba wax, whale wax, lanolin, silicone oil,
Liquid paraffin, ceresin, petrolatum, polyoxyethylene
Len (8 mol) oleyl alcohol ether, monoole
Oils such as glyceryl inate, capryl alcohol, laur
Ryl alcohol, myristyl alcohol, cetyl alcohol
Alcohol such as alcohol, cholesterol, phytostea
Sterols such as rolls, capric acid, lauric acid, millimeters
Stastic acid, palmitic acid, stearic acid, behenic acid,
Higher fats such as lanolin fatty acid, linoleic acid and linolenic acid
Acid, para-aminobenzoic acid, homomenthyl-7N-acetyl
Rualantranilate, butyl methoxybenzoyl meta
And di-paramethoxycinnamic acid-mono-2-ethylhexyl
Glyceryl sanate, amyl salicylate, octylcin
Purple such as namate and 2,4-dihydroxybenzophenone
External line absorbent, polyethylene glycol, glycerin, sodium
Rubitol, xylitol, maltitol, mucopolysaccharide,
Moisturizing hyaluronic acid, chondroitin sulfate, chitosan, etc.
Agent, methyl cellulose, ethyl cellulose, arabian moth
System, polyvinyl alcohol, montmorillonite, lavona
Thickeners such as ito, ethanol, 1,3-butylene glyco
Organic solvent such as alcohol, butylhydroxytoluene, tocov
Erol, antioxidants such as phytic acid, benzoic acid, sari
Cylic acid, sorbic acid, alkyloxy paraoxybenzoate
Ter (ethyl paraben, butyl paraben, etc.), hexac
Antibacterial preservatives such as lolofen, glycine, alanine, burr
, Leucine, serine, threonine, phenylalani
, Tyrosine, aspartic acid, asparagine, gluta
Amino acids such as min, taurine, arginine and histidine
And their alkali metal salts and hydrochlorides, acyl sarcosylates
Acids (eg lauroyl methyl sarcosine sodium
Etc.), organic acids such as glutathione, malic acid, tartaric acid, etc.
Tamine A and its derivatives, vitamin B6Hydrochloride, Vitamin
B6Tripalmitate, vitamin B6Dioctanoe
G, vitamin B2And its derivatives, vitamin B12, Vita
Min B 1FiveB vitamins such as and its derivatives, ascorbi
Acid, ascorbic acid sulfate (salt), ascorbi
Acid phosphate (salt), ascorbic acid dipalmite
Vitamin Cs, α-tocopherol, β-tocolate
Ferrol, γ-tocopherol, vitamin E acetate
Vitamin E nicotinate and other vitamin Es, vitamin
Bis such as vitamin D, vitamin H, pantothenic acid, and pantethine
Tamines, nicotinamide, benzyl nicotinate, γ
-Oryzanol, Allantoin, Glycyrrhizic acid
(Salt), glycyrrhetinic acid and its derivatives, hinokitio
, Muscidin, bisabolol, eucalyptol, chi
Mohr, inositol, saponins (saikosaponin,
Carrot saponin, loofah saponin, muclodisaponin
Etc.), pantothenyl ethyl ether, ethinyl estra
Various types of diol, cepharanthin, placenta extract, etc.
Drug, Rumex, Clara, Kouhone, Orange, Say
Ji, yarrow, mallow, senkyu, senbu
Re, thyme, spruce, spruce, perch, horsetail, hechi
Ma, horse chestnut, Yukinoshita, Arnica, lily, mugwort,
Organic of plants such as peony, aloe, gardenia, and mackerel
Solvent, alcohol, polyhydric alcohol, water, aqueous alcohol
Natural extract, pigment, sol monolaurate
Bitan, sorbitan monopalmitate, sesquiolein
Acid sorbitan, sorbitan trioleate, monolauri
Acid polyoxyethylene sorbitan, monostearic acid
Polyoxyethylene sorbitan, polyethylene glycol
Lumonooleate, polyoxyethylene alkyl ether
, Polyglycol diester, lauroyldiethanone
Luamide, fatty acid isopropanol amide, mulch
Tall hydroxy aliphatic ether, alkylated polysaccharide,
Non-ionic fields such as ruquil glucoside and sugar ester
Surface-active agent, stearyl trimethyl ammonium chloride
, Benzalkonium chloride, laurylamine oxide
Cationic surfactants such as sodium palmitate,
Sodium laurate, Sodium lauryl sulfate, Lau
Potassium rilsulfate, triethanolamine alkylsulfate
Ether, funnel oil, linear dodecyl benzene sulfate, po
Rioxyethylene hydrogenated castor oil maleic acid, acyl meth
Anionic surfactant such as lutarine, amphoteric surfactant
Agents, fragrances, purified water and the like can be added.
【0012】[0012]
【実施例】以下に実施例を挙げて本発明を具体的に説明
するが、本発明はこれらに限定されるものではない。
尚、配合量については、他に指定のない限り重量%を表
わす。 〔肌荒れ防止試験〕健常人男性の背部皮膚を3%のドデ
シル硫酸ナトリウム水溶液で処理し、肌荒れを作製し
た。2時間後、各試料水溶液を20μl開放塗布した。
これを5日間繰り返し、6日目に目視により肌荒れの状
態を観察し、表1の基準に従って採点した。評点が高い
ほど肌荒れ改善効果が高いことを示す。The present invention will be described in more detail with reference to the following examples, but the present invention is not limited thereto.
In addition, the compounding amount is represented by weight% unless otherwise specified. [Rough skin prevention test] The back skin of a healthy man was treated with a 3% sodium dodecyl sulfate aqueous solution to prepare rough skin. After 2 hours, 20 μl of each sample aqueous solution was applied in an open manner.
This was repeated for 5 days, and on the 6th day, the state of rough skin was visually observed and scored according to the criteria in Table 1. The higher the score, the higher the effect of improving rough skin.
【0013】[0013]
【表1】 ─────────────────────────────────── 評点 評 点 の 基 準 ─────────────────────────────────── 1 広範囲の角層の乾燥、めくれ、強い紅斑を認める。 2 角層の乾燥、めくれ、中程度の紅斑を認める。 3 角層の乾燥は認められるが、めくれは認められない。 弱い紅斑を認める。 4 角層の乾燥、めくれは認められないが、若干の紅斑を認める。 5 角層の乾燥、めくれ、紅斑共に認められない。 ───────────────────────────────────[Table 1] ─────────────────────────────────── Scores Standards of scores ───── ────────────────────────────── 1 A wide range of horny layer dryness, swelling, and strong erythema are observed. 2 Dry, swelling and moderate erythema on the stratum corneum. 3 Dryness of the stratum corneum is observed, but no curling is observed. Weak erythema. 4 Dryness and turning of the stratum corneum are not observed, but some erythema is observed. 5 Dryness, swelling and erythema of the stratum corneum are not observed. ───────────────────────────────────
【0014】被験男性は各群10人とし、10人の評点
の平均値を基に、各試料の肌荒れ改善効果を判定した。判定 ◎:評点の平均が4以上 ○:評点の平均が3以上4未満 △:評点の平均が2以上3未満 ×:評点の平均が2未満The test males were 10 in each group, and the skin roughening improving effect of each sample was judged based on the average value of the scores of 10 males. Judgment ◎: Average score is 4 or more ○: Average score is 3 or more and less than 4 Δ: Average score is 2 or more and less than 3 ×: Average score is less than 2
【0015】[0015]
【表2】 [Table 2]
【0016】表2より、NMF(乳酸ナトリウム)又は
エリスリトールの単独使用では肌荒れ改善効果が低い
が、これらを併用した系では肌荒れ防止効果が相乗的に
増大することが理解される。From Table 2, it is understood that the use of NMF (sodium lactate) or erythritol alone has a low skin roughening improving effect, but the system in which these are used together synergistically increases the skin roughening preventing effect.
【0017】[0017]
【表3】 ──────────────────────────────────── 試料 7 8 9 10 11 12 13 14 ──────────────────────────────────── 乳酸ナトリウム 10 20 30 40 5 10 15 20 エリスリトール − − − − 5 10 15 20 ──────────────────────────────────── 精製水 残 余 ──────────────────────────────────── 肌荒れ防止効果 △ ○ △ × ○ ◎ ◎ ◎ ────────────────────────────────────[Table 3] ──────────────────────────────────── Sample 7 8 9 9 10 11 12 12 13 14 ─ ─────────────────────────────────── Sodium lactate 10 20 30 40 5 5 10 15 20 Erythritol − − − − 5 10 15 20 ──────────────────────────────────── Purified water Residue ────── ────────────────────────────── Rough skin prevention effect △ ○ △ × ○ ◎ ◎ ◎ ◎ ───────── ────────────────────────────
【0018】表3より、従来のNMF(乳酸ナトリウ
ム)は低濃度では肌荒れ改善効果を有するもののその効
果は弱く、一方高濃度では紅斑等を生じ、かえって肌荒
れを増強する傾向が有った。これに対し、エリスルトー
ルを併用した系では肌荒れ改善効果が相乗的に向上し、
低濃度のNMFで優れた肌荒れ改善効果が得られた。From Table 3, conventional NMF (sodium lactate) has an effect of improving rough skin at low concentrations, but its effect is weak, while high concentration causes erythema and the like, and rather tends to enhance rough skin. On the other hand, in the system using erythritol in combination, the rough skin improving effect is synergistically improved,
An excellent effect of improving rough skin was obtained with a low concentration of NMF.
【0019】[0019]
【表4】 ──────────────────────────────────── 試料 15 16 17 18 19 20 21 22 ──────────────────────────────────── (NMF) クエン酸Na 10 − − − 5 − − NaCl − 10 − − − 5 − − KCl − − 10 − − − 5 − 酢酸Na − − − 10 − − − 5 ──────────────────────────────────── エリスリトール − − − − 5 5 5 5 ──────────────────────────────────── 水 残 余 ──────────────────────────────────── 肌荒れ防止効果 △ △ △ △ ○ ○ ○ ○ ──────────────────────────────────── 表4より、各種NMF成分とエリスリトールとの併用系
において、肌荒れ改善効果が増大することが理解され
る。[Table 4] ──────────────────────────────────── Sample 15 16 17 18 18 19 20 21 22 22 ─ ─────────────────────────────────── (NMF) Na citrate Na 10 − − − − 5 − − NaCl − 10 − − − 5 − − KCl − − 10 − − − − 5 − Acetic acid Na − − − 10 − − − 5 5 ───────────────────────── ──────────── Erythritol − − − − 5 55 5 5 ───────────────────────────── ─────── Water residue ──────────────────────────────────── Skin roughening prevention effect △ △ △ △ ○ ○ ○ ○ ───────────────── ────────────────── from Table 4, in combination systems with various NMF component and erythritol will be appreciated that rough skin improvement effect increases.
【0020】〔レプリカ法による実使用試験〕健康な女
性パネラーの顔面の皮膚表面形態をシリコーン樹脂によ
るレプリカ法を用いて肌のレプリカを採り、顕微鏡(1
7倍)にて観察した。皮絞の状態及び角層の剥離状態か
ら、表5に示す基準に基づいて肌荒れを評価し、評点が
1又は2と判断されたパネラーを1群20名とし、顔面
の右半分に表6記載の配合例1又は配合例2のローショ
ンを、左半分に比較例1のローションをそれぞれ1日2
回塗布した。2週間後、再びレプリカを採り、肌に状態
を観察、前記と同様とに評価した。[Actual Use Test by Replica Method] The skin surface morphology of the face of a healthy female panelist was replicated using a silicone resin replica method, and a microscope (1
7 times). Rough skin was evaluated based on the criteria shown in Table 5 based on the condition of the skin squeezing and the peeling state of the stratum corneum, and the panelists judged to have a score of 1 or 2 were 20 persons per group, and Table 6 is shown on the right half of the face. Lotion of Formulation Example 1 or Formulation 2 of Comparative Example 1 was applied to the left half for 2 days each.
It was applied twice. Two weeks later, a replica was taken again, and the condition of the skin was observed and evaluated in the same manner as above.
【0021】[0021]
【表5】 ─────────────────────────────────── 評点 評 点 の 基 準 ─────────────────────────────────── 1 皮溝、皮丘の消失、広範囲の角層のめくれが認められる 2 皮溝、皮丘が不鮮明、角層のめくれが認められる 3 皮溝、皮丘は認められるが、平坦 4 皮溝、皮丘が鮮明 5 皮溝、皮丘が鮮明で整っている ───────────────────────────────────[Table 5] ─────────────────────────────────── Scores Standards of scores ───── ────────────────────────────── 1 Skin clefts, disappearance of cuticles, and wide skin keratinization 2 skins Grooves and crusts are unclear, and horny layer is turned up. 3 Crusts and crusts are observed, but flat 4 Crusts, crusts are clear 5 Crusts, crusts are clear and regular ──── ───────────────────────────────
【0022】各群において、肌荒れ改善効果を次のよう
に判定した。判定 ○:評点が4又は5と評価されたパネラーの割合が75
%以上 △:評点が4又は5と評価されたパネラーの割合が25
%以上75%未満 ×:評点が4又は5と評価されたパネラーの割合が25
%未満 結果を表6に示す。In each group, the rough skin improving effect was judged as follows. Judgment ○: The proportion of panelists who were evaluated as 4 or 5 is 75
% Or more △: The proportion of panelists evaluated as 4 or 5 is 25
% Or more and less than 75% x: The proportion of panelists evaluated as 4 or 5 is 25
The results are shown in Table 6.
【0023】[0023]
【表6】 ─────────────────────────────────── 成分 配合例1 配合例2 比較例1 ─────────────────────────────────── 乳酸ナトリウム 1.5 1.0 3.0 KCl − 1.0 − エリスリトール 1.5 1.0 − ─────────────────────────────────── プロピレングリコール 1.0 1.0 1.0 クエン酸 0.2 0.2 0.2 95%エタノール 10.0 10.0 10.0 POE(20)ラウリルエーテル 0.5 0.5 0.5 香料 適量 適量 適量 精製水 残余 残余 残余 ─────────────────────────────────── 評価 ○ ○ △ ─────────────────────────────────── 表6から判るように、本発明にかかる皮膚外用剤は肌荒
れ改善効果に優れた皮膚外用剤である。[Table 6] ─────────────────────────────────── Component Composition example 1 Composition example 2 Comparative example 1 ─ ────────────────────────────────── Sodium lactate 1.5 1.0 3.0 KCl − 1.0 − Erythritol 1.5 1.0 − ─── ──────────────────────────────── Propylene glycol 1.0 1.0 1.0 Citric acid 0.2 0.2 0.2 95% Ethanol 10.0 10.0 10.0 POE ( 20) Lauryl ether 0.5 0.5 0.5 Perfume Suitable quantity Suitable quantity Purified water Residual residue Residual residue ─────────────────────────────────── ─ Evaluation ○ ○ △ ─────────────────────────────────── As seen from Table 6, the present invention Such an external preparation for skin improves rough skin It is an excellent skin external preparation in the results.
【0024】以下の配合例3〜11の皮膚外用剤を常法
により調製したところ、何れも肌荒れ防止、改善効果を
有し、また、丘疹、面疱、濃疱、紅斑等を発生すること
がない安全性の高い皮膚外用剤であった。When the external preparations for the skin of the following formulation examples 3 to 11 were prepared by a conventional method, they all had the effect of preventing and improving the rough skin, and were also capable of producing papules, comedones, blister, erythema and the like. It was a highly safe external preparation for skin.
【0025】配合例3 パック カオリン 70.8wt% タルク 23.0 プロピレングリコール 5.0 酢酸カルシウム 0.01 尿素 0.5 エリスリトール 0.3 KCl 0.1 香料 適 量 Formulation 3 Pack Kaolin 70.8 wt% Talc 23.0 Propylene glycol 5.0 Calcium acetate 0.01 Urea 0.5 Erythritol 0.3 KCl 0.1 Perfume Suitable amount
【0026】配合例4 栄養クリーム ステアリン酸 2.0wt% ステアリルアルコール 7.0 還元ラノリン 2.0 スクワラン 5.0 オクチルドデカノール 6.0 マルチトールヒドロキシラウリルエーテル 3.0 グリセリルモノステアレート 2.0 防腐剤 適 量 香料 適 量 プロピレングリコール 5.0 エリスリトール 10.0 乳酸カリウム 0.5 精製水 残 余 Formulation 4 Nourishing cream Stearic acid 2.0 wt% Stearyl alcohol 7.0 Reduced lanolin 2.0 Squalane 5.0 Octyldodecanol 6.0 Maltitol hydroxylauryl ether 3.0 Glyceryl monostearate 2.0 Antiseptic Agent Appropriate amount Perfume Appropriate amount Propylene glycol 5.0 Erythritol 10.0 Potassium lactate 0.5 Purified water Residual
【0027】配合例5 リップトリートメント キャンデリラロウ 9.0wt% 固形パラフィン 8.0 ミツロウ 5.0 カルナバロウ 5.0 ラノリン 11.0 ヒマシ油 残 余 エリスリトール 18.0 NaCl 10.0 イソプロピルミリステート 10.0 香料 適 量 酸化防止剤 残 余 Blending Example 5 Lip Treatment Candelilla Wax 9.0 wt% Solid Paraffin 8.0 Beeswax 5.0 Carnauba Wax 5.0 Lanolin 11.0 Castor Oil Residual Erythritol 18.0 NaCl 10.0 Isopropyl myristate 10.0 Fragrance Suitable amount Antioxidant Residue
【0028】配合例6 乳液 ステアリン酸 2.0wt% セタノール 1.0 ワセリン 3.0 ラノリンアルコール 2.0 流動パラフィン 8.0 スクワラン 2.0 エスカロール507 2.0 エリスリトール 10.0 HCl 0.5 ポリオキシエチレン(10)モノオレエート 2.5 トリエタノールアミン 1.0 プロピレングリコール 5.0 防腐剤 適 量 香料 適 量 精製水 残 余 Formulation Example 6 Emulsion stearic acid 2.0 wt% Cetanol 1.0 Vaseline 3.0 Lanolin alcohol 2.0 Liquid paraffin 8.0 Squalane 2.0 Escalol 507 2.0 Erythritol 10.0 HCl 0.5 Poly Oxyethylene (10) monooleate 2.5 Triethanolamine 1.0 Propylene glycol 5.0 Preservative A suitable amount Perfume Suitable amount Purified water Residual
【0029】配合例7 乳液 ステアリン酸 2.0wt% セタノール 1.0 ワセリン 3.0 ラノリンアルコール 2.0 流動パラフィン 8.0 スクワラン 2.0 エスカロール507 2.0 エリスリトール 1.5 乳酸ナトリウム 0.5 KCl 0.1 ポリオキシエチレン(10)モノオレエート 2.5 トリエタノールアミン 1.0 プロピレングリコール 5.0 防腐剤 適 量 香料 適 量 精製水 残 余 Formulation Example 7 Emulsion stearic acid 2.0 wt% Cetanol 1.0 Vaseline 3.0 Lanolin alcohol 2.0 Liquid paraffin 8.0 Squalane 2.0 Escalol 507 2.0 Erythritol 1.5 Sodium lactate 0.5 KCl 0.1 Polyoxyethylene (10) monooleate 2.5 Triethanolamine 1.0 Propylene glycol 5.0 Preservative A suitable amount Perfume Suitable amount Purified water Residual
【0030】配合例8 栄養クリーム ステアリン酸 2.0wt% ステアリルアルコール 7.0 還元ラノリン 2.0 スクワラン 5.0 オクチルドデカノール 6.0 マルチトールヒドロキシラウリルエーテル 3.0 グリセリルモノステアレート 2.0 防腐剤 適 量 香料 適 量 プロピレングリコール 5.0 エリスリトール 1.0 乳酸 0.3 クエン酸ナトリウム 0.5 イプシロンアミノカプロン酸 0.3 精製水 残 余 Formulation Example 8 Nourishing Cream Stearic Acid 2.0 wt% Stearyl Alcohol 7.0 Reduced Lanolin 2.0 Squalane 5.0 Octyldodecanol 6.0 Maltitol Hydroxylauryl Ether 3.0 Glyceryl Monostearate 2.0 Preservative Agent Amount Perfume Amount Propylene glycol 5.0 Erythritol 1.0 Lactic acid 0.3 Sodium citrate 0.5 Epsilon aminocaproic acid 0.3 Purified water Residual
【0031】配合例9 パック カオリン 65.0wt% タルク 19.0 プロピレングリコール 5.0 酢酸カルシウム 0.01 尿素 0.5 エリスリトール 0.2 香料 適 量 Formulation 9 Pack Kaolin 65.0 wt% Talc 19.0 Propylene glycol 5.0 Calcium acetate 0.01 Urea 0.5 Erythritol 0.2 Perfume Suitable amount
【0032】配合例10 リップトリートメント キャンデリラロウ 9.0wt% 固形パラフィン 8.0 ミツロウ 5.0 カルナバロウ 5.0 ラノリン 11.0 ヒマシ油 残 余 エリスリトール 20.0 乳酸カリウム 15.0 クエン酸ナトリウム 10.0 イソプロピルミリステート 10.0 香料 適 量 酸化防止剤 残 余 Blending Example 10 Lip Treatment Candelilla Wax 9.0 wt% Solid Paraffin 8.0 Beeswax 5.0 Carnauba Wax 5.0 Lanolin 11.0 Castor Oil Residual Erythritol 20.0 Potassium Lactate 15.0 Sodium Citrate 10. 0 Isopropyl myristate 10.0 Fragrance Suitable amount Antioxidant Residual
【0033】[0033]
【発明の効果】本発明の皮膚外用剤は、肌荒れ改善・予
防効果に優れ、また、丘疹、面疱、濃疱、紅斑等を発生
することがない安全性の高い皮膚外用剤である。The external preparation for skin of the present invention is a highly safe external preparation for skin, which is excellent in improving and preventing skin roughness and does not cause papules, blisters, vesicles, erythema and the like.
Claims (4)
2種以上とエリスリトールとを配合することを特徴とす
る皮膚外用剤。1. An external preparation for skin, comprising one or more natural moisturizing factor (NMF) components and erythritol.
然保湿因子(NMF)成分として乳酸及び/又は乳酸塩
を配合することを特徴とする皮膚外用剤。2. The external preparation for skin according to claim 1, which contains lactic acid and / or lactate as a natural moisturizing factor (NMF) component.
然保湿因子(NMF)成分としてクエン酸及び/又はク
エン酸塩を配合することを特徴とする皮膚外用剤。3. The external skin preparation according to claim 1, wherein citric acid and / or citrate is added as a natural moisturizing factor (NMF) component.
然保湿因子(NMF)成分としてNa+、Ca2+、Mg
2+、K+、PO4 3-又はCl-の中から少なくとも1種以
上を配合することを特徴とする皮膚外用剤。4. The external preparation for skin according to claim 1, wherein Na + , Ca 2+ and Mg are used as natural moisturizing factor (NMF) components.
An external preparation for skin, comprising at least one selected from 2+ , K + , PO 4 3− or Cl − .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2603794A JPH07215832A (en) | 1994-01-28 | 1994-01-28 | Skin external preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2603794A JPH07215832A (en) | 1994-01-28 | 1994-01-28 | Skin external preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH07215832A true JPH07215832A (en) | 1995-08-15 |
Family
ID=12182511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2603794A Pending JPH07215832A (en) | 1994-01-28 | 1994-01-28 | Skin external preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH07215832A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004075549A (en) * | 2002-08-12 | 2004-03-11 | Kanebo Ltd | Cosmetic |
| JP2006290845A (en) * | 2005-04-14 | 2006-10-26 | Kenji Nakamura | Cosmetic equipment |
| JP2009120564A (en) * | 2007-11-16 | 2009-06-04 | Maruha Nichiro Foods Inc | Hyaluronic acid production promoter |
| JP2011105621A (en) * | 2009-11-13 | 2011-06-02 | Nof Corp | Hyaluronidase activity inhibitor and external preparation for skin |
| JP2018021029A (en) * | 2016-08-04 | 2018-02-08 | エルジー ハウスホールド アンド ヘルスケア リミテッド | Skin corneum removing cosmetic composition with excellent moisturizing capacity |
-
1994
- 1994-01-28 JP JP2603794A patent/JPH07215832A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004075549A (en) * | 2002-08-12 | 2004-03-11 | Kanebo Ltd | Cosmetic |
| JP2006290845A (en) * | 2005-04-14 | 2006-10-26 | Kenji Nakamura | Cosmetic equipment |
| JP2009120564A (en) * | 2007-11-16 | 2009-06-04 | Maruha Nichiro Foods Inc | Hyaluronic acid production promoter |
| JP2011105621A (en) * | 2009-11-13 | 2011-06-02 | Nof Corp | Hyaluronidase activity inhibitor and external preparation for skin |
| JP2018021029A (en) * | 2016-08-04 | 2018-02-08 | エルジー ハウスホールド アンド ヘルスケア リミテッド | Skin corneum removing cosmetic composition with excellent moisturizing capacity |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3483988B2 (en) | Skin preparation | |
| JP3609834B2 (en) | Skin preparation | |
| JPWO1997002803A1 (en) | topical skin preparations | |
| JP3344822B2 (en) | External preparation for skin | |
| JP4070065B2 (en) | Skin preparation for preventing and improving skin roughness | |
| JPH11130652A (en) | Skin cosmetics | |
| JP2004075575A (en) | Cornoid lamella resolvent | |
| JPH0995432A (en) | Preparation for external use for skin | |
| JPH07215839A (en) | Skin external agent | |
| JPH07215838A (en) | Skin external agent | |
| JP2004307414A (en) | W/o/w emulsion skin care preparation for external use and method for producing the same | |
| JP3568983B2 (en) | Hair restorer | |
| JP2005132828A (en) | Composition for external application | |
| JP2594173B2 (en) | External preparation for skin | |
| JPH0995411A (en) | Preparation for external use for skin | |
| JPH115725A (en) | Preparation for external use for skin | |
| JP3001121B2 (en) | External preparation for skin | |
| JPH09263514A (en) | Preparation for external use for skin | |
| JP2003081805A (en) | Skin care preparation | |
| JP2681665B2 (en) | Cosmetics | |
| JP2001270828A (en) | External preparation for prevention and therapy of vulgaris acne and cosmetic prepared by formulating the same | |
| JP3638395B2 (en) | Topical skin preparation | |
| JPH08268866A (en) | Dermal preparation for external use | |
| JP2720247B2 (en) | External preparation for skin | |
| JPH05112442A (en) | External preparation of skin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20020702 |